MedPath

Study of the prevalence of aspirin sensitivity in patients with chronic rhinosinusitis and nasal polyposis coming to allergy department of Rasool-e-Akram hospital according to response to standard treatment after three months.

Phase 2
Conditions
chronic rhinosinusitis with nasal polyposis.
Other polyp of sinus Polyp of sinus: accessory ethmoidal maxillary sphenoidal
Registration Number
IRCT2015061322531N1
Lead Sponsor
Vce chancellor for research of Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

age 18-65 years old; presence of symptoms of chronic rhinosinusitis with nasal polyps which is documented on CT scan.
Exclusion criteria: existence of any serious underlying disease such as bleedin tendency, gastrointestinal, rheumatologic, malignancy, cardiac, renal, hepatic, psychological; history of IgE mediated reactions to aspirin or nonsteroidal anti inflammatory drugs; first second expiratory volume of more than 70 percent of predicted before aspirin challenge test; pregnancy; breast feeding; use of topical and systemic beta blockers; use of warfarin and warfarin derivates; mastocytosis; patients with poor cooperation and poor adherence.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of symptoms of chronic rhinosinusitis with nasal polyposis. Timepoint: after 3 months. Method of measurement: Sino Nasal Outcome Test (SNOT) questionnaire.
Secondary Outcome Measures
NameTimeMethod
Complications of conventional treatment including epistaxis, nasal burning sensation, nasal septal perforation, feeling sleepy. Timepoint: before intervention, three months after intervention. Method of measurement: history taking.
© Copyright 2025. All Rights Reserved by MedPath